Skip to Content

Research News at Vanderbilt

Symposium on impact of ‘omics on medicine set for March 23

|

First came genomics – the study of all things genetic. Then came proteomics – the study of proteins, the chemical machinery of everything living. They have been followed in rapid succession by a variety of other ‘omics: metabolomics, lipidomics, glycomics and more.

Instruments that can simultaneously identify tens of thousands of biological molecules play a key role in the 'omics revolution. (Jody May/Center for Innovative Technology, Vanderbilt)

Altogether, ‘omics represent a whole new perspective on how living systems work, which is having a revolutionary impact on medical theory and practice. That is the subject of a free one-day symposium being held March 23 at Vanderbilt University.

The symposium, “Integrated ‘Omics In Translational Medicine,” is sponsored by Vanderbilt University and the Waters Centers of Innovation Program and is open to all scientists interested in the subject. The symposium will feature presentations by a number of scientific thought leaders who will address the major instrumental and analytical challenges that the ‘omics fields are raising.

Waters Corporation, a global biomedical instrumentation producer, is supporting the symposium as part of its designation of Vanderbilt’s interdisciplinary Center of Innovative Technology, housed in the Department of Chemistry, as one of its 20 worldwide “Centers of Innovation” in recognition of the center’s contributions furthering ‘omics discovery and its translation into clinical practice.

The symposium, which begins at 9 a.m. and runs until 3 p.m., is free-of-charge. Lunch will be provided, but registration is required and space is limited. It will be held in Light Hall, Room 208.

Media Inquiries:
David Salisbury, (615) 322-NEWS
david.salisbury@vanderbilt.edu